Rockstroh JK, Paredes R, Cahn P, Molina JM, et al. Doravirine/islatravir (100/0.75 mg) once-daily compared to bictegravir/emtricitabine/tenofovir alafenamide as initial HIV-1 treatment: 48-week results from a phase 3, randomized, controlled, double-blind, non-inferiority trial. Clin Infect Dis 2025 Mar 13:ciaf077. doi: 10.1093.
PMID: 40079835